Harmony Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell HRMY and other ETFs, options, and stocks.About HRMY
Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical company, which engages in the provision of development and commercialization of therapies for the treatment of neurological disorders. Its product, WAKIX, is a molecule with a novel mechanism of action designed to increase histamine signaling in the brain by binding to H3 receptors.
CEOJeffrey M. Dayno
CEOJeffrey M. Dayno
Employees268
Employees268
HeadquartersPlymouth Meeting, Pennsylvania
HeadquartersPlymouth Meeting, Pennsylvania
Founded2017
Founded2017
Employees268
Employees268
HRMY Key Statistics
Market cap2.20B
Market cap2.20B
Price-Earnings ratio11.65
Price-Earnings ratio11.65
Dividend yield—
Dividend yield—
Average volume741.53K
Average volume741.53K
High today$38.44
High today$38.44
Low today$36.86
Low today$36.86
Open price$36.93
Open price$36.93
Volume757.23K
Volume757.23K
52 Week high$40.93
52 Week high$40.93
52 Week low$25.52
52 Week low$25.52
Stock Snapshot
As of today, Harmony Biosciences(HRMY) shares are valued at $38.40. The company's market cap stands at 2.2B, with a P/E ratio of 11.65.
On 2025-12-04, Harmony Biosciences(HRMY) stock traded between a low of $36.86 and a high of $38.44. Shares are currently priced at $38.40, which is +4.2% above the low and -0.1% below the high.
The Harmony Biosciences(HRMY)'s current trading volume is 757.23K, compared to an average daily volume of 741.53K.
In the last year, Harmony Biosciences(HRMY) shares hit a 52-week high of $40.93 and a 52-week low of $25.52.
In the last year, Harmony Biosciences(HRMY) shares hit a 52-week high of $40.93 and a 52-week low of $25.52.
Analyst ratings
82%
of 11 ratingsBuy
81.8%
Hold
9.1%
Sell
9.1%
People also own
Based on the portfolios of people who own HRMY. This list is generated using Robinhood data, and it’s not a recommendation.